Desvenlafaxine Tablet, Film Coated, Extended Release
Product Images NDC 63629-7524

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 63629-7524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

This text presents information related to renal and hepatic impairments, population description, gender, age, and PK (pharmacokinetics). The severity of renal and hepatic impairments is classified into four categories, including ESRD (End Stage Renal Disease). Additionally, this text includes a table with geometric mean ratios indicating the change relative to reference for parameters such as Cmax and AUC in PK studies.*

FDA Label Image

Figure2.jpg (Figure2)

This text appears to be reporting on the results of a study that measured the effects of the drug ketoconazole on the pharmacokinetics (PK) of CYP3A4 inhibitors. The results are expressed as geometric mean ratios, with a 90% confidence interval provided for each. The text also includes specific data on changes in Cmax, AuC, and T values due to ketoconazole, as well as the relative change compared to a reference.*

FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Figure4.jpg (Figure4)

The text describes a graph displaying the estimated proportion of patients with relapse and the time to relapse in days from randomization. The graph compares the performance of Desvenlafaxine 50mg with a Placebo. The X-axis of the graph represents time to relapse in days (ranging from 0 to 150 days), while the Y-axis represents the estimated proportion of patients with relapse (ranging from 0% to 100%).*

FDA Label Image

Figure5.jpg (Figure5)

FDA Label Image

Image 04

FDA Label Image

Label (Lbl636297524)

This is a package of Pristiq 25mg Tablets that have been prepackaged by Bryant Ranck. It can be compared to the same medication produced by West-Ward Columbus Inc. The package contains 30 tablets that expire on a certain month and year (MM/YY) and has an NDC number. The package should be stored between 20°C-25°C (68°F-77°F) at room temperature. The label also includes a warning to keep all drugs out of reach of children. The last line contains a series of numbers that may be a barcode or tracking code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.